News + Press

Explore by Category
BioCentury’s 2021 Class of Emerging Companies
February 14, 2022

BioCentury – BioCentury’s 2021 class of emerging companies

read more
BioCentury’s 2021 Class of Emerging Companies
February 14, 2022

BioCentury – BioCentury’s 2021 class of emerging companies

read more
Interius Bio Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform
December 09, 2021
read more
Pennovation Lab Welcomes New Tenant Interius BioTherapeutics to Its Innovation Ecosystem
October 05, 2021
read more
Interius Design: Penn Spinout Gets Specific with In Vivo CAR Ts
June 03, 2021
read more
Interius Biotherapeutics Nabs $76M Series A
May 18, 2021
read more
Penn Cell and Gene Therapy Spinout Interius Biotherapeutics Raises $76 Million
May 18, 2021
read more
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
May 18, 2021

Oversubscribed round co-led by Cormorant Asset Management and Fairmount Funds, supported by a strong syndicate…

read more